Table 2 The non-ST69/non-ST75 strains characterized via genomic analysis
Isolate ID | Genome ID (accession no)/Database | Genomic coverage (X) | Country of isolation | Year of isolation | ST | Source of isolation | O-serogroup (in silico) | AMR phenotype | AMR gene | Plasmids | Genomic Islands | ctxA/B | tcpA | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
195 | 2016_1 s(ERR6323226)/(EBI-ENA) | 195 | Iran | 2016 | 579 | Human | O1 | Pan susceptible | qnrVC4 | / | VPI-1 | / | wt | This study |
2134 | 2134/PubMLST | / | India | 2017 | 579 | Human | O1 | No data | qnrVC4 | / | VPI-1 | / | wt | PubMLST |
2106 | 2106/ PubMLST | / | Morocco | 2015 | 579 | Human | O1 | No data | qnrVC4 | / | VPI-1 | / | wt | PubMLST |
295 | CNRVC170253 (ERR6323228)/(EBI-ENA) | 171 | Iran | 2016 | 178 | Human | O1 | Pan susceptible | / | / | VSP-I | / | / | This study |
1884 | 1884/ PubMLST | / | Russia | 2004 | 178 | Human | O1 | No data | / | / | VSP-I | / | / | PubMLST |
1402 | 1402 /PubMLST | / | Ukraine | 2016 | 178 | Human | O1 | No data | / | / | VSP-I | / | / | PubMLST |
1403 | 1403/ PubMLST | / | Ukraine | 2017 | 178 | Human | O1 | No data | / | / | VSP-I | / | / | PubMLST |
491 | 2012_4 (ERR6323225)/(EBI-ENA) | 628 | Iran | 2012 | 438 | Human | O2 | Pan susceptible | / | / | / | / | / | This study |
391 | CNRVC170247 (ERR6323227)/(EBI-ENA) | 126 | Iran | 2012 | 983 | Human | O7 | Ampicillin | blaCARB-7/catB9 | / | / | / | / | This study |
495 | CNRVC170254 (ERR6323229)/(EBI-ENA) | 95 | Iran | 2016 | 984 | Human | O1 | Pan susceptible | / | / | / | / | / | This study |